Trials / Completed
CompletedNCT00689832
Protopic Ointment in Children Atopic Eczema
Comparative, Multicentre, Randomised, Double-blind Study to Assess the Efficacy of Tacrolimus 0.03% Ointment Versus Fluticasone 0.005% Ointment in Children Aged 2 Years or Over Suffering From Moderate to Severe Atopic Dermatitis.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 487 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 2 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
Children with atopic eczema and a poor response to topical corticosteroid applied either Protopic or Fluticasone ointment twice a day for 3 weeks. They could continue during 3 more weeks once a day if needed.
Detailed description
Treatments were to be applied twice daily until clearance, for a maximum of 3 weeks and then, in case of uncleared residual lesions, once daily for up to 3 further weeks. In the event of a flare-up the treatment was to be resumed twice a day until the end of the study. Statistical methods: An interim analysis was performed on 30% of the planned total sample size, i.e. 140 included patients who had completed the study, to reassess the assumptions made during the planning phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus 0.03% | ointment |
| DRUG | Fluticasone 0.005% | ointment |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2008-06-04
- Last updated
- 2014-09-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00689832. Inclusion in this directory is not an endorsement.